Abstract
Background & aims
Significant liver repopulation by hepatocyte transplantation will advance clinical applications. The aim of this study was to test the hypothesis that translocation of transplanted cells into liver plates will allow repeated cell transplantation for increasing the transplanted hepatocyte mass.Methods
Hepatocytes were transplanted via spleen from either F344 rats into syngeneic recipients deficient in dipeptidyl peptidase IV or from transgenic hepatitis B surface antigen-producing G26 mice with hepatitis B virus into nontransgenic congeneic recipients. Portosystemic shunting was shown by radiological methods.Results
Repeated hepatocyte transplantation led to progressively increased liver repopulation. Transplantation of 1.75 x 10(8) hepatocytes in three divided doses repopulated more than an estimated 5% of the host rat liver, with 3.8 x 10(6) +/- 0.1 x 10(6) transplanted cells/cm3 liver. This was a tenfold or threefold mean increase in transplanted cell number compared with recipients of 2.0 x 10(7) or 7.5 x 10(7) cells transplanted in single sessions, respectively (P < 0.001). Repeated hepatocyte transplantation interfered with neither cell integrations in liver parenchyma nor secretory function of transplanted cells. Portal hypertension, portasystemic collaterals, or intrahepatic shunting were not observed in cell recipients.Conclusions
Repeated transplantation of hepatocytes in large numbers is safe and effective and should advance strategies for liver repopulation.Citations & impact
Impact metrics
Citations of article over time
Article citations
Cell and Tissue Therapy for the Treatment of Chronic Liver Disease.
Annu Rev Biomed Eng, 23:517-546, 11 May 2021
Cited by: 6 articles | PMID: 33974812 | PMCID: PMC8864721
Review Free full text in Europe PMC
Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease.
Stem Cells Transl Med, 10(6):829-835, 06 Feb 2021
Cited by: 5 articles | PMID: 33547875 | PMCID: PMC8133340
Hepatocyte transplantation: past efforts, current technology, and future expansion of therapeutic potential.
J Surg Res, 226:48-55, 10 Feb 2018
Cited by: 11 articles | PMID: 29661288 | PMCID: PMC6558656
Review Free full text in Europe PMC
Human hepatocyte transplantation for liver disease: current status and future perspectives.
Pediatr Res, 83(1-2):232-240, 06 Dec 2017
Cited by: 92 articles | PMID: 29149103
Review
Cell therapy for liver disease: From liver transplantation to cell factory.
J Hepatol, 62(1 suppl):S157-69, 01 Apr 2015
Cited by: 158 articles | PMID: 25920085
Review
Go to all (75) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule.
Hepatology, 23(3):482-496, 01 Mar 1996
Cited by: 105 articles | PMID: 8617428
Transcatheter hepatocyte transplantation: preclinical studies of anatomic consequences in the portal vascular bed.
Acad Radiol, 1(3):229-236, 01 Nov 1994
Cited by: 4 articles | PMID: 9419491
Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis.
J Pathol, 191(1):78-85, 01 May 2000
Cited by: 35 articles | PMID: 10767723
Liver repopulation with hepatocyte transplantation: new avenues for gene and cell therapy.
J Gene Med, 1(6):386-392, 01 Nov 1999
Cited by: 13 articles | PMID: 10753063
Review
Funding
Funders who supported this work.
NIDDK NIH HHS (2)
Grant ID: R01 DK 46952
Grant ID: DK K08 01909
PHS HHS (1)
Grant ID: P30 41296